Track topics on Twitter Track topics that are important to you
LONDON, August 3, 2017 /PRNewswire/ --
North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing
The global pharmaceutical contract manufacturing market was valued at $76.6bn in 2016 and is expected to grow at a CAGR of 6.6% in the first half of the forecast period. Between 2011 and 2016, the top 5 emerging market CMOs grew at a CAGR of 13.6%, whereas the leading developed market CMOs grew at a CAGR of 1.7% over the same period.
How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 311-page report you will receive 184 tables and 111 figures - all unavailable elsewhere.
The 311-page report provides clear detailed insight into the pharmaceutical CMOs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
• Global Pharmaceutical Contract Manufacturing Market forecast from 2017-2027:
• API Manufacturing
• FDF Manufacturing
• Other Services
• This report profiles 30 leading CMOs in North America, Europe, Japan, China and India:
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Teva API
• Esteve Quimica
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy's Laboratories
• The content of each profile differs, depending on the organisation. In general, a profile gives the following information:
• Overview of the company's contract manufacturing services and operations
• Analysis of recent financial performance - annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments - activities, acquisitions, production capacity, deals, new service offerings and collaborations
• SWOT analysis - a firm's strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2016 onwards
• Forecasting of pharmaceutical manufacturing revenue to 2027, as well as projected operating profit and margin for some companies.
Buy our report today Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027: North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing.
To request a report overview of this report please email Sara Peerun at firstname.lastname@example.org or call Tel: +44-(0)-20-7336-6100
Companies Mentioned in the Report:
Alliance Medical Products
Banner Life Sciences
Baxter BioPharma Solutions
Becton and Dickinson (BD)
Beijing Double-Crane Pharmaceutical
Bristol-Myers Squibb (BMS)
China National Pharmaceutical Group (SInopharm)
Corvette Pharmaceutical Services
Dr. Reddy's Laboratories
Dragenopharm Apotheker Püschl and Swiss Caps
Euro Vital Pharma
Fuyang Xinghai Investment
Hejiang Jiang Yuan Tang Biotechnology
Human Genome Sciences
International Chemical Investors Group
Johnson & Johnson (J&J)
LBO Italia Investimenti s.r.l
Poli Industria Chimica
Sanwa Kagaku Kenkyusho
Sentry BioPharma Services
Shandong Tianda Biological Pharmaceutica
Shandong Xinhua Pharmaceutical
Swedish Orphan Biovitrium AB (Sobi)
Teva Pharmaceutical Industries
Tianjin Tianyo Pharmaceuticals
Vivante GMP Solutions
Yiwu Huayi Investment
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Hisun Pharmaceutical
Zhejiang Huahai Pharmaceuticals
To see a report overview please email Sara Peerun on email@example.com
SOURCE Visiongain LtdNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...